Using Bayh-Dole Act March-In Rights to Lower US Drug Prices

This cross-setional study examines the feasibility of using march-in rights under the Bayh-Dole Act to systemically lower drug prices by removing patent barriers to competition using data from the Food and Drug Administration Orange Book

from JAMA Health Forum New Online https://ift.tt/WVe57Ym